Changes in tubulin-β4 (TUBB4B) and acylglycerophosphate acyltransferase (AGPAT) expressions have been reported with respect to tumor progression and clinic outcomes of cancer patients [28–31]. The gene discussed is TUBB4B; the disease is neoplasm.